Hikal Company Description
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals industries.
The company operates in two segments, Pharmaceuticals and Crop Protection. It provides anti-convulsant, anti-inflammatory, analgesic, anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, anti-viral, and haemorheologic products; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries.
The company also manufactures pesticides and herbicides, including diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT.
In addition, it engages in contract research, custom synthesis, and custom manufacturing of intermediates and active pharmaceutical ingredients.
The company operates in India, the United States, Canada, Europe, South East Asia, and internationally.
The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000.
Hikal Limited was incorporated in 1988 and is based in Navi Mumbai, India.
| Country | India |
| Founded | 1988 |
| Industry | Pharmaceutical Preparations |
| Employees | 2,152 |
| CEO | Sameer Hiremath |
Contact Details
Address: Great Eastern Chambers Navi Mumbai, 400614 India | |
| Phone | 91 22 6277 0299 |
| Website | hikal.com |
Stock Details
| Ticker Symbol | 524735 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sameer Hiremath | Chief Executive Officer |
| Kuldeep Jain | Chief Financial Officer |